Spinal Decompression

Spinal Decompression is a non-invasive treatment that is gentle and very comfortable, providing the patient with welcomed relief. Spinal decompression provides an influx of fluids, oxygen, and nutrients into the spinal disc. Discs are essentially avascular and depend on diffusion from the essentially bony vertebra above and below to satisfy their nutrient requirements. Distraction creates a pressure differential resulting in water, oxygen, and nutrients being drawn into the disc, ultimately promoting a healthy spine.

Spinal Decompression Treatment Inclusion Criteria

• Pain that has lasted over one month and generated from a process other than herniation
• Degenerative disc disease
• Herniated disc disease and bulges
• Back pain that lasts longer than one week
• Sciatica
• Posterior facet syndrome
• Spinal stenosis/arthritis

Most independent studies for Spinal Decompression  available today were done on a table called “VAX-D”.  Our Non-Surgical Spinal Decompression procedure uses the prodedures followed by the VAX-D.  The following is a list of some of the research using the VAX-D.

Anesthesiology News, (Vol. 29, No. 3, March 2003)

Vax-D Reduces Chronic Discogenic Lo Back Pain-4 Year Study. OUTCOME: Four year follow-up after Vax-D treatment shows a sustained 86% reduction in pain and that 91% of patients had resumed their normal activities.

Journal of Neurologic Research (Vol. 29, No. 3, March 2003)

Efficacy of Vertebral Axial Decompression on Chronic Low Back Pain. OUTCOME: This 144 patient study showed 76% achieved remission of pain. Except in emergent conditions, VaxX-D should be used on all conditions before surgery is undertaken.

Journal of Orthopedic & Sports Physical Therapy (Vol.35, No.1, January 2005)

Short and Long-term Outcomes Following Treatment with the Vax-D protocol for Patients with Chronic, Activity-limiting Low Back Pain.   OUTCOME: Significant improvements in a sample of patients with unfavorable prognosis due to chronic low back pain.

Neurological Research Journal (Vol. 23, p. 706-714, October 2001)  

Dermatosomal Somatosensory Evoked Potential Demonstration of Nerve Root Decompression after Vax-D Therapy. OUTCOME: Pain reduction in the study group was 77% with successful decompression of the nerve roots at multiple levels.

Canadian Journal of Clinical Medicine (Vol. 5, No.1, January 1998)

The effects of Vax-D on sensory nerve function in Patients with Low Back Pain and Radiculopathy. OUTCOME: The average pain reduction was 77%

For Further Research Articles Please Inquire